28
Oct
2016

Amgen Increases Prices (Again), Humana Flexes Muscle, and MIT Starts a $150M Engine

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.

You may also like

GSK Partners With Vir on Antibodies, Pfizer With BioNTech on Vaccines, & the Testing Fiasco Continues
A Baffling Coronavirus Response, Arch & Flagship Reload, & Merck Passes 2 Phase IIIs
The Coronavirus Tsunami, Lyell’s $492M Megaround & Some Deals You Missed
COVID-19: Collective Problem-Solving Time